Search clinical trials for: Amantadine, Ribavirin, Oseltamivir

Total 1040 results

National Institute of Allergy and Infectious Diseases...

Completed

Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications (IRC003)

Influenza

United States, Australia, Argentina, Mexico, Thailand
Hospices Civils de Lyon

Terminated

Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection (Combina)

Influenza A Infection

France
Hoffmann-La Roche

Completed

A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers

Healthy Volunteer

United States
Novartis
Hoffmann-La Roche

Completed

Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine

Healthy

United States
Assistance Publique - Hôpitaux de Paris
GlaxoSmithKline; Hoffmann-La Roche

Terminated

Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir (BIVIR)

Gastric Influenza

France
Adamas Pharmaceuticals, Inc.

Completed

Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects (PO206)

Influenza

United States, Australia, Canada, Netherlands, Singapore
University Hospital, Bordeaux
Hoffmann-La Roche

Completed

Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients (PEGARI)

Hepatitis C, Chronic | HCV Infection

France
Fred Hutchinson Cancer Center

Completed

TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Influenza

United States
University of Hamburg-Eppendorf
Hoffmann-La Roche; Universitätsklinikum Hamburg-Eppendorf

Unknown

Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy

Hepatitis C, Chronic | Relapse

Germany
Aga Khan University

Completed

Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders

Hepatitis C | Genotype 3 | Non-responders | Relapsers

Pakistan
Centre of Postgraduate Medical Education

Unknown

Different Regimens in Influenza Postexposure Chemoprophylaxis in Children

Influenza | Prevention | Exposure

Poland
GlaxoSmithKline

Completed

A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers

Influenza, Human

United States
French National Agency for Research on AIDS and...
Schering-Plough

Terminated

Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders

Hepatitis C, Chronic

France
Hoffmann-La Roche

Completed

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Influenza

Italy, United States, Spain, Hungary, France, Lithuania, Romania, Poland, Denmark
The University of Hong Kong

Completed

Convalescent Plasma Treatment in Severe 2009 H1N1 Infection

Influenza A

China
Capital Medical University

Unknown

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Qingdao Municipal Hospital; Beijing Luhe Hospital; Cangzhou People's Hospital; First... and other collaborators

Unknown

Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms

Severe Influenza

China
Guangdong Raynovent Biotech Co., Ltd

Completed

A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A

Influenza A

China
Laboratorios Andromaco S.A.

Completed

Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product

Bioequivalence

India
Capital Medical University

Completed

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study

Influenza

China
University Hospital, Limoges
Hoffmann-La Roche

Completed

Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM (CINAM)

Chronic Hepatitis C

France
The Affiliated Hospital of Qingdao University

Completed

Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension

Healthy Subjects

China
Dalian Zhen-Ao Bio-Tech Co., Ltd.

Unknown

Phase IIaTrials of GanMaoKangNing Granules

Epidemic Influenza

China
The First Affiliated Hospital of Guangzhou Medical...

Unknown

Lingdancao Granules in the Treatment of Seasonal Influenza

Influenza
South East Asia Infectious Disease Clinical Research...
University of Oxford

Completed

Open-Label Pharmacokinetic of Oseltamivir in Healthy Obese Thai Adult Subjects

Healthy

Thailand
China Academy of Chinese Medical Sciences
Renmin Hospital of Wuhan University; Children's Hospital of Soochow University and other collaborators

Unknown

Clinical Study of Reduning Injection for the Treatment of Influenza in Children

Influenza in Children
Assiut University

Recruiting

Oral Amantadine, IV Amantadine and Hemodynamic Response to Laryngoscopy

Intubation, Intratracheal

Egypt
IWK Health Centre
Hoffmann-La Roche; Nova Scotia Health Authority; Dalhousie University; Canadian...

Completed

Oseltamivir Pharmacokinetics in Morbid Obesity (OPTIMO)

Morbid Obesity

Canada
Hoffmann-La Roche

Terminated

A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.

Influenza

Italy
Hoffmann-La Roche

Completed

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

Influenza

United States, Lebanon, Israel
Hoffmann-La Roche

Completed

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Influenza

United States, Denmark, Canada
University of Louisville
Centers for Disease Control and Prevention

Completed

Rapid Empiric Treatment With Oseltamivir Study (RETOS) (RETOS)

Pneumonia | Influenza

United States
Hutchison Whampoa Guangzhou Baiyunshan Chinese...
Guangzhou Institute of Respiratory Disease

Unknown

Banlangen Granules Anti-seasonal Influenza Study (BLG)

Influenza

China
National Institute of Allergy and Infectious Diseases...

Completed

Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza

Influenza

United States, Canada
University Medical Centre Ljubljana

Completed

Prophylactic Treatment With Oseltamivir

Influenza, Human

Slovenia
Ziv Hospital
Hillel Yaffe Medical Center

Unknown

Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?

Hepatitis C

Israel
Hospital District of Southwestern Finland
Hoffmann-La Roche

Completed

Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age (ETOPOM)

Influenza

Finland
Hoffmann-La Roche

Completed

A Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine Clearance

Healthy Volunteer

New Zealand
GlaxoSmithKline

Completed

Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza

Virus Diseases

United States, South Africa, Australia
University of Manitoba
Hoffmann-La Roche

Withdrawn

Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit

Influenza A Virus Infection | Influenza B Virus Infection

Canada
Tongji Hospital

Recruiting

Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients

ST Elevation Myocardial Infarction | STEMI

China
University of Pittsburgh
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Withdrawn

A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy

Pregnancy | Influenza

United States
Hoffmann-La Roche

Completed

A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.

Influenza, Human

United States, Spain, Belgium, Poland, Germany, United Kingdom, Chile, Estonia, Hungary, Italy, France, South Africa, Mexico, Israel, Brazil, Guatemala, Czechia, Lithuania, Argentina, Bulgaria, Canada, Colombia, Latvia, Romania, Switzer... and more
Genentech, Inc.

Completed

A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model

Healthy Volunteer

United Kingdom
Daiichi Sankyo Co., Ltd.

Completed

A Multinational Phase III Study of CS-8958 (MARVEL) (MARVEL)

Influenza, Human

Taiwan, Japan, Korea, Republic of, China
Nanjing Zenshine Pharmaceuticals

Recruiting

A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects (ZX-7101A-208)

Drug Interaction

China
Centers for Disease Control and Prevention
Universidad del Valle, Guatemala; Hospital Nacional San Juan de Dios de Santa... and other collaborators

Terminated

Panama and El Salvador Children's Oseltamivir Study (PECOS)

Influenza | Human Influenza

Panama, El Salvador
Composite Interceptive Med Science

Unknown

Influenza Management With Polyherbal Formulation

Influenza

India
GlaxoSmithKline

Withdrawn

A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects

Healthy Subjects
National Institute of Allergy and Infectious Diseases...

Completed

Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients (HEPCPR)

HIV Infections | Hepatitis C

United States

Search clinical trials for: Amantadine, Ribavirin, Oseltamivir

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations